Clinical Trial Update: Study of Clinical Course of Newly Diagnosed Moderate to Severe Ulcerative Colitis in Korea

View source ↗

Summary

A completed clinical trial in Korea sponsored by Janssen Korea studied the clinical course of newly diagnosed moderate-to-severe ulcerative colitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Snippet

Sponsor: Janssen Korea, Ltd., Korea | Conditions: Colitis, Ulcerative | Status: COMPLETED